THRAP3P3

Across TCGA pan-cancer cohorts, THRAP3P3 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated THRAP3P3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher THRAP3P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated THRAP3P3 expression acts as an unfavorable survival marker, although some lineages such as READ and UVM show a favorable association.

STAD, ACC, and KIRP are the cancer types where THRAP3P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Quartile	III,IV	0.139	0.629	<.001	84	view →
ACC	DFS	Median	II,III,IV	0.151	0.725	.001	37	view →
KIRP	OS	Quartile	IV	0.166	0.502	.005	36	view →
READ	DFS	Quartile	All	0.956	0.773	.004	29	view →
LUAD	OS	Quartile	II,III,IV	0.526	0.711	.013	20	view →
LIHC	OS	Median	III,IV	0.406	0.733	<.001	20	view →
UVM	DFS	Tertile	III,IV	1.000	0.548	.022	12	view →
GBM	OS	Tertile	All	0.569	0.290	.002	12	view →
COAD	DFS	Tertile	IV	0.263	0.581	<.001	11	view →
BLCA	OS	Median	III,IV	0.767	0.637	.018	7	view →
LUSC	OS	Quartile	III,IV	0.557	0.739	.015	7	view →
ESCA	OS	Tertile	IV	0.398	0.743	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

THRAP3P3–STAD (OS)

Open the STAD breakdown →